Category Archives: Health

Latest From
Health

Forbes’ GMO Answers column looks at the tremendous potential of animal biotechnology to combat human disease. Under the theme “One Health,” these technologies – and the roadblocks that are preventing them for commercialization – are the focus on this week’s Animal Biotech Summit in Bethesda, Md. Today’s column was authored by Eddie Sullivan, Ph.D., CEO and co-founder of SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical development company in Sioux Falls, S.D. SAB’s technology (described below) Read More >

It can only mean one thing when long summer days have come to an end, school is back in session, and cooler temperatures are on the horizon with the arrival of fall – flu season is coming! As influenza activity begins to rise in October, be prepared and plan to protect yourself, your family, and those around you by getting your annual flu vaccine. The CDC advises that everyone six months and older get vaccinated Read More >

Writing in The Hill, National Organization for Rare Disorders (NORD) President and CEO Peter Saltonstall called upon Congress to act swiftly to maintain an important program encouraging research into treatments for rare pediatric diseases. The Rare Pediatric Priority Review Voucher (PRV) Program is set to expire at the end of the month, unless Congress reauthorizes it. Saltonstall writes: Developing therapies for people with rare diseases is incredibly difficult. Rare diseases are scientifically and medically complex, Read More >

BIO is undertaking an aggressive effort to promote the value of biopharmaceutical innovations and ensure that all patients have access to the drugs they need. A vital component of this campaign is holding insurers and their allies accountable for standing in the way of that access. For months, we’ve blown the whistle on their discriminatory practices, high cost-sharing and cost-shifting, and their blatant falsehoods on what’s driving their premium increases, and today, we’re introducing a Read More >

Last week, the Washington Post published an article titled Alzheimer’s Drug Trial Sparks Optimism which highlighted new findings from a paper published in Nature. They shared exciting news of positive early trial results for a potential new Alzheimer’s treatment. “Overall this is the best news that we’ve had in my 25 years doing Alzheimer’s clinical research and it brings new hope for patients and families most affected by the disease,” said one of the study’s Read More >